- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01733849
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
An Observational Study to Estimate the Disease Burden of Rotavirus Gastroenteritis in Infants/Children Less Than Five Years of Age in Primary Care Settings, in Bulgaria and Latvia
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
A Primary care setting will include independent general practitioners (GP) (specialised in paediatrics) or independent paediatricians.
Stool samples will be collected from all enrolled subjects at Visit 1 (Day 0) and tested immediately after collection. The stool sample will be stored for 24 hours only, in case the test cannot be performed immediately after collection.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
-
Burgas, Bulgarien, 8000
- GSK Investigational Site
-
Burgas, Bulgarien, 8018
- GSK Investigational Site
-
Dobrich, Bulgarien, 9300
- GSK Investigational Site
-
Pazardzik, Bulgarien, 4400
- GSK Investigational Site
-
Pleven, Bulgarien, 5800
- GSK Investigational Site
-
Plovdiv, Bulgarien, 4000
- GSK Investigational Site
-
Ruse, Bulgarien, 7000
- GSK Investigational Site
-
Sliven, Bulgarien, 8800
- GSK Investigational Site
-
Sofia, Bulgarien, 1606
- GSK Investigational Site
-
Sofia, Bulgarien, 1505
- GSK Investigational Site
-
Sofia, Bulgarien, 1517
- GSK Investigational Site
-
Sofia, Bulgarien, 1528
- GSK Investigational Site
-
Stara Zagora, Bulgarien, 6000
- GSK Investigational Site
-
Varna, Bulgarien, 9000
- GSK Investigational Site
-
Veliko Turnovo, Bulgarien, 5000
- GSK Investigational Site
-
-
-
-
-
Balvi, Lettland, LV-4501
- GSK Investigational Site
-
Bauska, Lettland, LV-3901
- GSK Investigational Site
-
Broceni, Lettland, LV-3851
- GSK Investigational Site
-
Carnikava, Lettland, LV-2163
- GSK Investigational Site
-
Daugavpils, Lettland, LV-5401
- GSK Investigational Site
-
Daugavpils, Lettland, LV-5410
- GSK Investigational Site
-
Druva, Lettland, LV-3862
- GSK Investigational Site
-
Erglu pagasts, Lettland, LV-4840
- GSK Investigational Site
-
Grobina, Lettland, LV-3430
- GSK Investigational Site
-
Ikskile, Lettland, LV-5052
- GSK Investigational Site
-
Jekabpils, Lettland, LV-5201
- GSK Investigational Site
-
Jelgava, Lettland, LV-3001
- GSK Investigational Site
-
Jelgava, Lettland, LV-3002
- GSK Investigational Site
-
Jelgava, Lettland, LV-3007
- GSK Investigational Site
-
Jelgava, Lettland, LV-3008
- GSK Investigational Site
-
Kuldiga, Lettland, LV-3300
- GSK Investigational Site
-
Liepaja, Lettland, LV-3401
- GSK Investigational Site
-
Limbazi, Lettland, LV-4001
- GSK Investigational Site
-
Livani, Lettland, LV-5316
- GSK Investigational Site
-
Madona, Lettland, LV-4801
- GSK Investigational Site
-
Ogre, Lettland, LV-5001
- GSK Investigational Site
-
Ozolnieki, Lettland, LV-3018
- GSK Investigational Site
-
Pinki, Lettland, LV-2107
- GSK Investigational Site
-
Rezekne, Lettland, LV-4601
- GSK Investigational Site
-
Rezekne, Lettland, LV-4604
- GSK Investigational Site
-
Riga, Lettland, LV-1001
- GSK Investigational Site
-
Riga, Lettland, LV-1002
- GSK Investigational Site
-
Riga, Lettland, LV-1010
- GSK Investigational Site
-
Riga, Lettland, LV-1011
- GSK Investigational Site
-
Riga, Lettland, LV-1012
- GSK Investigational Site
-
Riga, Lettland, LV-1024
- GSK Investigational Site
-
Riga, Lettland, LV-1050
- GSK Investigational Site
-
Riga, Lettland, LV-1063
- GSK Investigational Site
-
Riga, Lettland, LV-1082
- GSK Investigational Site
-
Ropazi, Lettland, LV-2135
- GSK Investigational Site
-
Sigulda, Lettland, LV-2150
- GSK Investigational Site
-
Tukums, Lettland, LV-3101
- GSK Investigational Site
-
Valmiera, Lettland, LV-4200
- GSK Investigational Site
-
Valmiera, Lettland, LV-4201
- GSK Investigational Site
-
Vangazi, Lettland, LV-2136
- GSK Investigational Site
-
Ventspils, Lettland, LV-3601
- GSK Investigational Site
-
Ventspils, Lettland, LV-3602
- GSK Investigational Site
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Infants/children with home visits by the GPGP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for AGE treatment during the study period.
- A male or female infant/child less than five years of age at the time of the GP/paediatrician visit. A child becomes ineligible on the day of her/his fifth birthday.
- Written informed consent obtained from the parents/legally acceptable representative (LARs) of the subject.
- Subjects who the investigator believes that his/her, parents/LARs can and will comply with the requirements of the protocol.
Exclusion Criteria:
• Child in care.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: Kohorte
- Zeitperspektiven: Interessent
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Group Bulgaria
Subjects in this group include infants/children from Bulgaria, less than five years of age with home visits by the GP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for the treatment of AGE.
|
Samples will be tested to determine the presence or absence of rotavirus.
Log books
|
Group Latvia
Subjects in this group include infants/children from Latvia, less than five years of age with home visits by the GP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for the treatment of AGE.
|
Samples will be tested to determine the presence or absence of rotavirus.
Log books
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Number of RV GE cases among the acute gastroenteritis (AGE) cases reported at primary care settings in infants/children less than five years of age.
Zeitfenster: At the time of enrollment of each subject (Day 0).
|
At the time of enrollment of each subject (Day 0).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Symptoms related to AGE and their measures, stratified by rotavirus status for all the AGE cases reported by infants/children less than five years of age at the primary care settings.
Zeitfenster: Day 0 - Day 14+5 (At the time of phone call follow-up contact).
|
Day 0 - Day 14+5 (At the time of phone call follow-up contact).
|
Number of RV GE cases reported at each month by infants/children less than five years of age reported at the primary care settings.
Zeitfenster: At the time of enrollment of each subject (Day 0).
|
At the time of enrollment of each subject (Day 0).
|
Number of hospitalisations for RV GE and AGE, reported at the primary care settings.
Zeitfenster: At the time of phone call follow-up contact (14 to 19 days after enrollment).
|
At the time of phone call follow-up contact (14 to 19 days after enrollment).
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Tafalla M, Gardovska D, Gopala K, Kozlovska L. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis. Hum Vaccin Immunother. 2019;15(6):1272-1278. doi: 10.1080/21645515.2018.1534515. Epub 2018 Oct 31.
- Tiholova M, Gopala K, Berberova M, Strokova-Stoilova M, Tafalla M. Rotavirus gastroenteritis in children less than five years of age in primary care settings in Bulgaria: an observational study. Germs. 2016 Sep 1;6(3):97-105. doi: 10.11599/germs.2016.1095. eCollection 2016 Sep.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 116621
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Infektionen, Rotaviren
-
GlaxoSmithKlineAbgeschlossenRotavirus-Infektion | Rotavirus-ImpfstoffeVereinigte Staaten
-
PATHBill and Melinda Gates Foundation; Children's Hospital Medical Center, Cincinnati und andere MitarbeiterAbgeschlossen
-
Taipei Medical University Shuang Ho HospitalUnbekannt
-
National Institute of Pediatrics, MexicoMerck Sharp & Dohme LLC; Centro Nacional para la Salud de la Infancia y la AdolescenciaAbgeschlossen
-
GlaxoSmithKlineAbgeschlossenRotavirus-Gastroenteritis | Nosokomiale Rotavirus-Gastroenteritis
-
Seattle Children's HospitalNational Center for Research Resources (NCRR); Thrasher Research FundAbgeschlossenDarmversagen | Rotavirus-ImpfstoffeVereinigte Staaten
-
Romark Laboratories L.C.AbgeschlossenRotavirus-Infektion | Virale Gastroenteritis durch RotavirusÄgypten
-
PATHAbgeschlossenRotavirus-InfektionVereinigte Staaten
-
Merck Sharp & Dohme LLCAbgeschlossen
-
PATHAbgeschlossenBewertung eines Rotavirus-ImpfstoffsSüdafrika
Klinische Studien zur Stool sample
-
Hillel Yaffe Medical CenterUnbekannt